Prescribing information

 

Explore our Autumn meeting series, Dermatology 2020: A virtual reality, to hear experts discuss highlights from the latest guidelines, as well as data updates and top tips on evolving clinical practice in a virtual world.

 

Bringing real-world evidence to life: BADBIR highlights

 

Dr Christos Kasparis and Dr Fiona Craig discuss the latest analysis by the BADBIR group. Watch this video to learn more about how you can use real-world evidence to guide clinical decision making.

Want to see more of the data for yourself? Explore the latest analysis from the BADBIR group

 

 

Click here for Cosentyx®(secukinumab) prescribing information

 

 

Why PsA matters in PsO: GRAPPA and EXCEED Highlights

 

Dr Amy Foulkes and Dr William Tillett discuss the importance of PsA and its varying manifestations in the treatment of plaque psoriasis. They also present the latest treatment guidance and head-to-head data for Cosentyx in PsA.

Cosentyx has 5 years of proven efficacy in PsO and PsA.1,2 You can explore more of the evidence here

 

 

Click here for Cosentyx®(secukinumab) prescribing information

 

 

The benefits of a dedicated nurse-led service: You First Highlights

 

Dr Christos Kasparis shares his experience of the You First programme for patients on Cosentyx, with a specific focus on how it has helped his clinic and his patients at a time of increased pressure on capacity.

Find out more about how your patients could benefit from the nurse-led support programme. See the You First programme

 

 

Click here for Cosentyx®(secukinumab) prescribing information

 

Register to see more highlights from this series below, such as Top tips for Virtual PsO Management and Highlights of the 2020 BAD Guidelines

 

Top tips for Virtual PsO Management

 

Tracy Bale, MSc, shares her top tips for conducting virtual consultations, with a focus on how we can continue to measure disease activity in the new normal, with limited face-to-face clinics.

To help you support your Cosentyx patients, virtually or face to face, we have digitised our Cosentyx patient resources. Access them here

Click here for Cosentyx®(secukinumab) prescribing information

 

 

BAD Guidelines 2020: Highlights

 

Dr Andrew Pink and Dr Christos Kasparis share their insights on the updated BAD guidelines, which focus on biologic therapy for plaque psoriasis. Watch now to hear about the key changes and how this can impact decision making in your practice.

BAD, British Association of Dermatologists; BADBIR, British Association of Dermatologists Biologic and Immunomodulators Register; PsA, psoriatic arthritis; PsO, plaque psoriasis.

References

  1. Bissonnette R et al. J Eur Acad Dermatol Venereol 2018;32:1507–1514.  
  2. Mease P et al. ACR Open Rheum 2020;2(1):18–25.
     
UK | January 2021 | 100660
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]